Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or planned fundraising through debt or equity in the transcript. The company is focusing on progressive capacity expansion with capital expenditure (capex) of INR 50-60 crores planned for FY '24-'25. Capex is mainly for completing the Mahad plant and adding balancing equipment at Panipat and Cheyyar plants. The management is cautious about further capex depending on Pharma segment growth, which might require additional capacity expansion mid-year if the business develops well. No direct references were made to raising funds via new loans or equity is

Any current/future capex/capital investment/strategic investment?

Capex of INR 50-60 crores planned for FY '24-'25, including building the Mahad plant (~INR 20 crores) and balancing equipment/ construction at Panipat and Cheyyar (~INR 15-20 crores). Progressive capacity expansion from current 47,000 tons to ~60,000 tons by end of FY '25. Pharma capacity enhancement under consideration, potentially starting mid-FY '24-'25 if market response remains positive. Continuous capex expected over 1-1.5 years focusing on Pharma and other segments. New facilities: Panipat plant inauguration planned by February end; Cheyyar plant started January. Pharma produc

Future growth expectations in sales/revenue/volumes?

Volume growth target for FY '24-'25 is at least 15-20%, with potential for up to 20% in thin wall Food & FMCG segment. Capacity expected to increase from current 47,000 tons to about 57,000-60,000 tons by end of next financial year. Pharma packaging capacity expansion may start mid-FY '24-'25, potentially driving significant future growth. Square Packs (Qpacks) have shown over 100% volume growth, expected to grow 30-40% next year. Paint segment volume growth expected to return to double digits with new plants and clients like ABG and Asian Paints. EBITDA margin aimed to cross 20% within 1-2 ye

Future growth expectations in earnings/operating earnings/profits/EPS?

EBITDA margin is close to 18.9%, expected to cross 20% during FY '24-'25 if Pharma segment progresses well; else, may take 1 more year. (Page 14) EBITDA per kg targeted to improve back to INR 40 in FY '24-'25 and likely improve further with Pharma success. (Pages 14, 12) Revenue growth depends on raw material prices; volume growth targeted at 15-20% for next financial year. (Page 14) Pharma segment expected to contribute 5-8% to top line from year 2 onwards, progressively improving EBITDA per kg. (Pages 12, 14) Food and FMCG segment set to grow by 20% in next financial year, driven by Panipat

Current/ Expected Orderbook/ Pending Orders?

Mold-Tek Packaging operates mostly on a rolling order basis with major clients, who give monthly orders based on demand. There is no fixed or large pending order book as such; smaller clients place orders periodically based on their needs. Major clients like Asian Paints and others have open orders with monthly price revisions linked to raw material fluctuations. The company maintains an open order system rather than a backlog of pending orders. This approach allows flexibility in managing production according to client requirements without accumulating a large pending order book.

Mold-Tek Packaging LtdQ3 FY24Industrial Products

Mold-Tek Packaging Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹272.85P/E: 23.9Market Cap: ₹1.8K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Volume growth target for FY '24-'25 is at least 15-20%, with potential for up to 20% in thin wall Food & FMCG segment.
Capacity expected to increase from current 47,000 tons to about 57,000-60,000 tons by end of next financial year.
Pharma packaging capacity expansion may start mid-FY '24-'25, potentially driving significant future growth.
Square Packs (Qpacks) have shown over 100% volume growth, expected to grow 30-40% next year.
Paint segment volume growth expected to return to double digits with new plants and clients like ABG and Asian Paints.
EBITDA margin aimed to cross 20% within 1-2 years, driven by Pharma and other segments.
Revenue growth impacted by raw material prices but volume growth expected to translate into higher sales.

Margin guidance

Category 1

EBITDA margin is close to 18.9%, expected to cross 20% during FY '24-'25 if Pharma segment progresses well; else, may take 1 more year. (Page 14)
EBITDA per kg targeted to improve back to INR 40 in FY '24-'25 and likely improve further with Pharma success. (Pages 14, 12)
Revenue growth depends on raw material prices; volume growth targeted at 15-20% for next financial year. (Page 14)
Pharma segment expected to contribute 5-8% to top line from year 2 onwards, progressively improving EBITDA per kg. (Pages 12, 14)
Food and FMCG segment set to grow by 20% in next financial year, driven by Panipat plant ramp-up and new products. (Pages 9, 12, 14)
Paint segment shipment volumes expected to increase with new plant (Satara) coming online, aiming for double-digit growth next year. (Page 14)
Continuous capex of INR 50-60 crores planned for FY '24, '25 supporting capacity ramp-up to 57,000-60,000 tons by end FY '25. (Pages 17-18)

See what Mold-Tek Packaging Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

There is no explicit mention of any current or planned fundraising through debt or equity in the transcript.
The company is focusing on progressive capacity expansion with capital expenditure (capex) of INR 50-60 crores planned for FY '24-'25.
Capex is mainly for completing the Mahad plant and adding balancing equipment at Panipat and Cheyyar plants.
The management is cautious about further capex depending on Pharma segment growth, which might require additional capacity expansion mid-year if the business develops well.
No direct references were made to raising funds via new loans or equity issuance; existing financial costs have increased due to recent investments.
Overall, fundraising plans, if any, were not disclosed or discussed in this transcript.

Order book

Mold-Tek Packaging operates mostly on a rolling order basis with major clients, who give monthly orders based on demand.
There is no fixed or large pending order book as such; smaller clients place orders periodically based on their needs.
Major clients like Asian Paints and others have open orders with monthly price revisions linked to raw material fluctuations.
The company maintains an open order system rather than a backlog of pending orders.
This approach allows flexibility in managing production according to client requirements without accumulating a large pending order book.

See what Mold-Tek Packaging Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Capex of INR 50-60 crores planned for FY '24-'25, including building the Mahad plant (~INR 20 crores) and balancing equipment/ construction at Panipat and Cheyyar (~INR 15-20 crores).
Progressive capacity expansion from current 47,000 tons to ~60,000 tons by end of FY '25.
Pharma capacity enhancement under consideration, potentially starting mid-FY '24-'25 if market response remains positive.
Continuous capex expected over 1-1.5 years focusing on Pharma and other segments.
New facilities: Panipat plant inauguration planned by February end; Cheyyar plant started January.
Pharma product lines (effervescent tubes, canisters, HDPE bottles, CRC caps) targeted for commercial production by end of calendar year 2024, peak production by Q1 FY '25.
Focus on capacity utilization and new product launches at Panipat to drive Food & FMCG growth.
Exports for effervescent tubes and canisters expected to start next financial year.

Track Mold-Tek Packaging Ltd — get its next earnings analysis in your feed

How does Mold-Tek Packaging Ltd rank vs peers in Industrial Products?

Pro feature

ThisMold-Tek Packaging Ltd

Rev 3Mar 1

See where Mold-Tek Packaging Ltd sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Mold-Tek Packaging Ltd rank in Industrial Products?

Compare Mold-Tek Packaging Ltd against every Industrial Products company (Q3 FY24) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What Mold-Tek Packaging Ltd's management said in earlier quarters

Others in Industrial Products this season

Captain Polyplast Ltd (Q2 FY27)
32.9% increase . Key results statement takeaways from Captain Polyplast Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Shyam Metalics & Energy Ltd (Q2 FY27)
Q2 FY27 Revenue:** ₹5,960.2 crore, up 33.4% YoY (Page 38) . Key investor presentation takeaways from Shyam Metalics & Energy Ltd's Q2 FY27 investor presentation
Ratnaveer Precision Engineering Ltd (Q2 FY27)
Q2 FY27 Revenue: ₹3,872.37 million . Key investor presentation takeaways from Ratnaveer Precision Engineering Ltd's Q2 FY27 investor presentation — and how it r
HEG Advanced Materials Ltd (Q2 FY27)
For the quarter ended September 30, 2026, HEG Limited reported total revenue from operations of ₹1,520.64 crores. Key results statement takeaways from HEG Advan

Compare:vs Cummins India vs Polycab India vs Welspun Corp Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →